• T2B Monthly
  • Posts
  • DIRECT access to MM+M’s Editor-in-Chief

DIRECT access to MM+M’s Editor-in-Chief

With a T2B Pro membership

Hi!

There’s another exclusive perk for T2B Pro members we’re so thrilled to share: Our new private Slack channel with Jameson Fleming, editor-in-chief of MM+M.

Pro members can use this space to get real-time access to Jameson to discuss industry topics, respond to his calls for sources, or even DM him privately to pitch ideas.

This is the first time we’ve been able to offer this level of access to a reporter, and it signifies our dedication to helping the biopharma community build great relationships with the media (and, likewise, be good resources for them in return).

The Lowdown on Jameson and MM+M

First published in 1966 as Medical Marketing + Media, MM+M covers a mix of online breaking news and analysis combined with monthly print features – timely, objective, original editorial content for an executive audience of leaders and thinkers who work in pharma, medical device, diagnostics, and greater healthcare marketing.

Jameson is adept at focusing on trends, marketing, and digital transformation. He aims to ensure biopharma marketers feel seen by MM+M through coverage and analysis that reflect a deep understanding of their issues and what makes them successful.

“MM+M wants to cultivate closer connections with the mar-comm decision makers who are often the front door into the brand. I hope this leads to more vibrant storytelling by MM+M about the topics and issues the pharma industry wants to read more about," Jameson said of this new partnership.

This type of ongoing community-wide dialogue with media is a concept we’ve hoped to bring to life for a while now. So, we’re really pleased to have found a partner in Jameson, who believes in the collective power and wisdom of all of you! T2B Pro members can start chatting with Jameson right away on the private MM+M Slack channel.

Lynnea

P.S: This private Slack channel is just one of many ways a T2B Pro membership can help boost your media engagement.

Did someone forward this to you?
Or better yet